Chr del(17p) + Chr del(11q)	Chronic Lymphocytic Leukemia	Chr del(17p) + Chr del(11q)	Chronic Lymphocytic Leukemia	ibrutinib + UC-961 Sensitive: C3 – Early Trials ibrutinib + UC-961 Sensitive : C3	ibrutinib + UC-961 Sensitive: C3 – Early Trials ibrutinib + UC-961 Sensitive : C3
Chr del(11q)	Chronic Lymphocytic Leukemia	Chr del(11q)	Chronic Lymphocytic Leukemia	ibrutinib + UC-961 Sensitive: C3 – Early Trials ibrutinib + UC-961 Sensitive : C3	ibrutinib + UC-961 Sensitive: C3 – Early Trials ibrutinib + UC-961 Sensitive : C3
Chr del(17p)	Chronic Lymphocytic Leukemia	Chr del(17p)	Chronic Lymphocytic Leukemia	ibrutinib + UC-961 Sensitive: C3 – Early Trials ibrutinib + UC-961 Sensitive : C3	ibrutinib + UC-961 Sensitive: C3 – Early Trials ibrutinib + UC-961 Sensitive : C3
TP53 mutation	Mantle Cell Lymphoma	TP53 mutation	Mantle Cell Lymphoma	ibrutinib + UC-961 Sensitive: C3 – Early Trials ibrutinib + UC-961 Sensitive : C3	ibrutinib + UC-961 Sensitive: C3 – Early Trials ibrutinib + UC-961 Sensitive : C3
TP53 mutation	Chronic Lymphocytic Leukemia	TP53 mutation	Chronic Lymphocytic Leukemia	ibrutinib + UC-961 Sensitive: C3 – Early Trials ibrutinib + UC-961 Sensitive : C3	ibrutinib + UC-961 Sensitive: C3 – Early Trials ibrutinib + UC-961 Sensitive : C3
MRD4 negative	Mantle Cell Lymphoma	MRD4 negative	Mantle Cell Lymphoma	NVG-111 Sensitive: C3 – Early Trials NVG-111 Sensitive : C3	NVG-111 Sensitive: C3 – Early Trials NVG-111 Sensitive : C3
MRD4 negative	Chronic Lymphocytic Leukemia	MRD4 negative	Chronic Lymphocytic Leukemia	NVG-111 Sensitive: C3 – Early Trials NVG-111 Sensitive : C3	NVG-111 Sensitive: C3 – Early Trials NVG-111 Sensitive : C3
ROR1 expression	Prostate Cancer	ROR1 expression	Prostate Cancer	UC-961 Sensitive: D – Preclinical UC-961 Sensitive : D	UC-961 Sensitive: D – Preclinical UC-961 Sensitive : D
ROR1 positive	Lung Cancer	ROR1 positive	Lung Cancer	GNC-035 Sensitive: D – Preclinical GNC-035 Sensitive : D	GNC-035 Sensitive: D – Preclinical GNC-035 Sensitive : D

ROR1 inhibitor

ROR1 inhibitor

Associations(9)

Associations
(9)